top of page
Treat Beyond the Clot.
Get Back to What Matters.
Real-time data to guide clinical decisions when treating blood clots in the lungs
Pulmonary embolism (PE)- 3rd leading cause of cardovascular death in US
.png)
Pulmonary embolisms every year in the US
.png)
of PE survivors suffer persistent functional or physical limitations
1 yr post-PE
Clinicians need accessible, advanced therapies that provide precise, real-time data to take the guesswork out of reperfusion and give them confidence that treatment is working and heart function is recovering.
The Versus® Catheter
Hemodynamic-Guided Thrombolysis
Know When Treatment is Working.
Know When Treatment is Done.
Versus is the only FDA-cleared catheter pairing bilateral therapy delivery with integrated real-time pulmonary artery pressure monitoring in a single device for precise, personalized treatment.
Derek Hall
Co-founder, COO
John Schindler
Co-founder, CEO
Leadership Team
Board of Directors
Gabriele Niederaurer, PhD
Board Chair, Advisor
Mary Byron
Board Member, Advisor
Paul Sartori
Board Member, Advisor
Delivering Accessible, Advanced Reperfusion
Our Partners
bottom of page